AGTR2 and Alzheimer disease: We investigated the underlying mechanism and found that AT2 receptor aggregation in AD is a disease-specific process with two consecutive cross-linking steps, i.e., mediated by (i) reactive oxygen species (ROS), and (ii) transglutaminase.